Second line therapy in patients with primary biliary cholangitis and inadequate response to UDCA: are we choosing the right target population for clinical trials?

被引：0
|
作者：
Villamil, Alejandra [1 ]
de la Vina, Daniela [1 ]
Mullen, Eduardo [1 ]
Lucero, Ignacio [1 ]
Sobenko, Natalia [1 ]
Bandi, Juan Carlos [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-185
引用
收藏
页码：S342 / S343
页数：2
相关论文
共 50 条
  • [1] Fenofibrate in Primary Biliary Cholangitis Patients With Inadequate Response to Ursodeoxycholic Acid (UDCA)
    Khaykis, Inessa
    Sherman, Alex
    Tobias, Hillel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S501 - S501
  • [2] ADDITIVE BENEFICIAL EFFECTS OF FIBRATES COMBINED WITH OBETICHOLIC ACID IN THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO SECOND-LINE THERAPY
    Soret, Pierre-Antoine
    Lam, Laurent
    Carrat, Fabrice
    Smets, Lena
    Leroy, Vincent
    Berg, Thomas
    Carbone, Marco
    Invernizzi, Pietro
    Trivedi, Palak
    Weiler-Normann, Christina
    Alric, Laurent
    Rosa, Isabelle
    Cervoni, Jean-Paul
    Dumortier, Jerome
    Potier, Pascal
    Roux, Olivier
    Silvain, Christine
    Levy, Cynthia
    Pares, Albert
    Schramm, Christoph
    Nevens, Frederick
    Chazouilleres, Olivier
    Corpechot, Christophe
    HEPATOLOGY, 2019, 70 (06) : 1491A - 1492A
  • [3] Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA
    Duan, Weijia
    Ou, Xiaojuan
    Wang, Xiaoming
    Wang, Yu
    Zhao, Xinyan
    Wang, Qianyi
    Wu, Xiaoning
    Zhang, Wei
    Ma, Hong
    You, Hong
    Jia, Jidong
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (09) : 557 - 563
  • [4] Primary biliary cholangitis: histological criteria to predict UDCA therapy response - a case series
    Naranjo-Hans, D.
    Gimeno Beltran, J.
    Puche Gallego, A.
    Serrano Munne, L.
    Masso Castella, J.
    Garcia-Retortillo, M.
    Lloveras Rubio, B.
    VIRCHOWS ARCHIV, 2020, 477 : S94 - S94
  • [5] External Validation of UDCA Response Score in Slovak and Croatian Patients with Primary Biliary Cholangitis
    Gazda, Jakub
    Janicko, Martin
    Drazilova, Sylvia
    Grgurevic, Ivica
    Kanizaj, Tajana Filipec
    Koller, Tomas
    Bodorovska, Beatrica
    Mijic, Maja
    Mikolasevic, Ivana
    Stromar, Ivana Knezevic
    Kucinsky, Branislav
    Gazda, Matej
    Jarcuska, Peter
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 2021
  • [6] THE EFFECTIVE USE OF BEZAFIBRATE AS A SECOND LINE THERAPY FOR PRIMARY BILIARY CHOLANGITIS
    Howden, Adam
    Valliani, Talal
    GUT, 2021, 70 : A21 - A22
  • [7] In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis
    Lens, Sabela
    GASTROENTEROLOGY, 2024, 167 (03) : 623 - 624
  • [8] Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes
    Cheung, A. C.
    Lapointe-Shaw, L.
    Kowgier, M.
    Meza-Cardona, J.
    Hirschfield, G. M.
    Janssen, H. L. A.
    Feld, J. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (02) : 283 - 293
  • [9] Time to initiation of the second-line therapy obeticholic acid in patients with primary biliary cholangitis
    Kumar, Sonal
    MacEwan, Joanna P.
    Levine, Alina
    Bessonova, Leona
    Nair, Radhika
    Wheeler, Darren
    Li, Jing
    Brown, Robert S., Jr.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S314 - S315
  • [10] Time to Initiation of the Second-Line Therapy Obeticholic Acid in Patients With Primary Biliary Cholangitis
    Kumar, Sonal
    Macewan, Joanna P.
    Levine, Alina
    Bessonova, Leona
    Nair, Radhika
    Wheeler, Darren
    Li, Jing
    Brown, Robert S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S91 - S91
12345